Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.740
-0.110 (-2.86%)
At close: Dec 5, 2025, 4:00 PM EST
3.850
+0.110 (2.94%)
After-hours: Dec 5, 2025, 7:58 PM EST
Prime Medicine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 5.98 | 2.98 | - | - | - | 5.21 | Upgrade
|
| Cost of Revenue | 160.03 | 155.29 | 147.91 | 86.73 | 70.55 | 2.98 | Upgrade
|
| Gross Profit | -154.05 | -152.31 | -147.91 | -86.73 | -70.55 | 2.23 | Upgrade
|
| Selling, General & Admin | 49.91 | 50.16 | 43.39 | 29.82 | 13.92 | 3.16 | Upgrade
|
| Operating Expenses | 49.91 | 50.16 | 43.39 | 29.82 | 13.92 | 3.16 | Upgrade
|
| Operating Income | -203.96 | -202.47 | -191.29 | -116.54 | -84.47 | -0.93 | Upgrade
|
| Interest & Investment Income | 4.6 | 3.52 | 2.81 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.14 | 0.04 | 0.27 | 1.9 | -80.99 | -11.48 | Upgrade
|
| EBT Excluding Unusual Items | -199.22 | -198.9 | -188.21 | -114.64 | -165.46 | -12.41 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.88 | 3.02 | 3.3 | -8.13 | -0.39 | 10.87 | Upgrade
|
| Other Unusual Items | - | - | -13.5 | - | - | - | Upgrade
|
| Pretax Income | -197.34 | -195.88 | -198.41 | -122.77 | -165.85 | -1.54 | Upgrade
|
| Income Tax Expense | - | - | -0.28 | -0.95 | -0.49 | 1.87 | Upgrade
|
| Net Income | -197.34 | -195.88 | -198.13 | -121.82 | -165.37 | -3.41 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 20.19 | 18.75 | 1.65 | Upgrade
|
| Net Income to Common | -197.34 | -195.88 | -198.13 | -142.01 | -184.12 | -5.06 | Upgrade
|
| Shares Outstanding (Basic) | 137 | 119 | 91 | 34 | 13 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 137 | 119 | 91 | 34 | 13 | 3 | Upgrade
|
| Shares Change (YoY) | 25.86% | 30.37% | 168.41% | 161.23% | 391.47% | 77.53% | Upgrade
|
| EPS (Basic) | -1.44 | -1.65 | -2.18 | -4.19 | -14.19 | -1.91 | Upgrade
|
| EPS (Diluted) | -1.44 | -1.65 | -2.18 | -4.19 | -14.19 | -1.91 | Upgrade
|
| Free Cash Flow | -115.1 | -130.16 | -174.14 | -147.92 | -38.23 | -6.18 | Upgrade
|
| Free Cash Flow Per Share | -0.84 | -1.10 | -1.91 | -4.37 | -2.95 | -2.34 | Upgrade
|
| Gross Margin | - | - | - | - | - | 42.80% | Upgrade
|
| Operating Margin | -3412.48% | -6787.36% | - | - | - | -17.89% | Upgrade
|
| Profit Margin | -3301.64% | -6566.61% | - | - | - | -97.02% | Upgrade
|
| Free Cash Flow Margin | -1925.63% | -4363.36% | - | - | - | -118.68% | Upgrade
|
| EBITDA | -196.8 | -196.34 | -186.64 | -114.32 | -83.91 | -0.89 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -17.06% | Upgrade
|
| D&A For EBITDA | 7.16 | 6.13 | 4.65 | 2.22 | 0.57 | 0.04 | Upgrade
|
| EBIT | -203.96 | -202.47 | -191.29 | -116.54 | -84.47 | -0.93 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -17.89% | Upgrade
|
| Revenue as Reported | 5.98 | 2.98 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.